Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
F AloraifiJ G Geraghty

Abstract

Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetime. However, only about 20% of familial breast cancer is attributed to mutations in BRCA1 and BRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. Despite extensive efforts to explain the missing heritability of this disease, the majority of familial clustering in breast cancer remains largely unexplained. We aim to analyze the pathology of familial cases of which no pathogenic mutation is yet identified. We compared the pathological phenotype of BRCA1/BRCA2 negative familial breast cancer (BRCAx) to BRCA1-positive, BRCA2-positive and sporadic cases without a family history. Age-adjusted analysis is summarized in odd's ratios and confidence intervals for tumor type, grade, lymph node, ER and HER2 status. We found non-familial cases to be more likely to be ER positive (P = 0.041) as compared with BRCAx tumors. More cases of lobular carcinoma were found with BRCAx as compared to BRCA1 tumors (P = 0.05). After multivariate logistic regression analysis, BRCAx tumors are more likely ER positive (P = 0.001) and HER2 posi...Continue Reading

References

May 1, 1996·Nature Genetics·M R NelenC Eng
Jan 14, 1999·The New England Journal of Medicine·L C HartmannR B Jenkins
Mar 21, 2000·American Journal of Human Genetics·A BroeksL J van 't Veer
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·T KainuH Nevanlinna
Jul 21, 2001·The New England Journal of Medicine·H Meijers-HeijboerJ G Klijn
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sunil R LakhaniDouglas F Easton
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly MetcalfeSteven A Narod
Jul 30, 2004·The New England Journal of Medicine·Mieke KriegeUNKNOWN Magnetic Resonance Imaging Screening Study Group
Jul 5, 2005·Journal of Medical Genetics·D G R EvansN Rahman
Sep 1, 2005·The Lancet Oncology·Diana M Eccles, Gabriella Pichert
Mar 23, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rogier A OldenburgPeter Devilee
Jan 4, 2007·Nature Genetics·Nazneen RahmanMichael R Stratton
May 1, 2008·Pathology·Maurice LoughreyRosemary L Balleine
Jun 12, 2008·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·J PalaciosJ Benítez
Jun 20, 2008·Breast Cancer Research and Treatment·Anita L BaneIrene L Andrulis
May 14, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Leonard Da Silva, Sunil R Lakhani
Sep 4, 2010·Genes, Chromosomes & Cancer·Rosemary L BalleineGraham J Mann
Mar 15, 2011·Journal of Mammary Gland Biology and Neoplasia·Ana Cristina VargasSunil R Lakhani
Jun 7, 2011·The New England Journal of Medicine·Paul E GossUNKNOWN NCIC CTG MAP.3 Study Investigators
May 4, 2013·Lancet·Jack CuzickUNKNOWN SERM Chemoprevention of Breast Cancer Overview Group
Apr 24, 2014·Future Oncology·Kelly-Anne Phillips, Geoffrey J Lindeman

❮ Previous
Next ❯

Citations

Apr 24, 2020·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Marilyn M LiUNKNOWN ACMG Professional Practice and Guidelines Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Related Papers

BioMed Research International
Paraskevi Apostolou, F Fostira
JAMA : the Journal of the American Medical Association
Tom WalshMary-Claire King
European Journal of Human Genetics : EJHG
Tim RippergerBrigitte Schlegelberger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Lorenzo MelchorJ Benítez
© 2022 Meta ULC. All rights reserved